Clinical Trial Update: Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination [Phase 4]

View source ↗

Summary

Phase 4 study evaluating humoral and cellular immune responses in low- and high-responders after tick-borne encephalitis vaccination. The study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• Tick-borne encephalitis vaccine (Tick-borne encephalitis vaccine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Tick-borne Encephalitis | Phase 4 | Status: COMPLETED